6 hours Castle Biosciences (CSTL) Upgraded to Strong Buy: Here’s What You Should Know Zacks
Castle Biosciences (CSTL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).